Lymphatic Filariasis Archives – Page 2 of 2

Global programme to eliminate lymphatic filariasis: progress report, 2015

Français, WHO Weekly Epidemiological Record

Global programme to eliminate lymphatic filariasis: progress report, 2015. Weekly Epidemiological Record. WHO, 2016 Overview Lymphatic filariasis (LF) is a vector-borne neglected tropical disease.

September 30, 2016

Job Aid: Disease-specific Assessments for Lymphatic Filariasis

Français, Resources and Tools

Job aid in English and French versions (see below). ENVISION, August 2016.

August 30, 2016

Training in Monitoring and Epidemiological Assessment of Mass Drug Administration for Eliminating Lymphatic Filariasis: Learner’s Guide (Portuguese version)

Português, WHO Guide

Learner’s Guide for the training program (Portuguese version). WHO, 2015.

December 14, 2015

Global programme to eliminate lymphatic filariasis: progress report, 2014

Français, WHO Weekly Epidemiological Record

Global programme to eliminate lymphatic filariasis: progress report, 2014. Weekly Epidemiological Record. WHO, 2015 Overview Lymphatic filariasis (LF) is targeted for global elimination as

September 18, 2015

GSK’s Albendazole Donation

Videos

A video from GlaxoSmithKline (GSK) describing lymphatic filariasis and their donation of the drug albendazole to help make elimination of LF a reality.

July 11, 2015

Training in Monitoring and Epidemiological Assessment of Mass Drug Administration for Eliminating Lymphatic Filariasis: Facilitator’s Guide (French version)

Français, WHO Guide

Ce guide a été conçu pour enseigner aux membres du personnel des programmes nationaux d’élimination de la FL, notamment le personnel de santé aux

December 30, 2014

Training in Monitoring and Epidemiological Assessment of Mass Drug Administration for Eliminating Lymphatic Filariasis: Facilitator’s Guide

WHO Guide

This manual is designed to teach personnel of national programmes to eliminate lymphatic filariasis, including regional and district health personnel, the essential elements of monitoring and

December 14, 2013

Lymphatic Filariasis: Managing Morbidity and Preventing Disability

WHO Guide

Note: There is a newer (2021) edition of this guide available, called Lymphatic filariasis: managing morbidity and preventing disability: an aide-mémoire for national programme

July 13, 2013

Monitoring and Epidemiological Assessment of Mass Drug Administration in the Programme to Eliminate Lymphatic Filariasis: Transmission Assessment Survey (TAS) Guidelines, A Manual for National Elimination Programmes

Français, Português, WHO Guide

This document focuses on updating procedures for monitoring and evaluation in line with the program’s first component: to interrupt transmission of LF through MDA. Available in

July 12, 2011

The sharp end — experiences from the Tanzanian programme for the elimination of lymphatic filariasis: notes from the end of the road

This article provides an insight of how the Tanzania Lymphatic Filariasis Programme began and discusses key areas in the programme’s design. Malecela et al, Annals

July 20, 2009

The Global Programme to Eliminate Lymphatic Filariasis: health impact during its first 8 years (2000–2007)

Scientific Publication

Abstract on the first 8 years of The Global Programme to Eliminate Lymphatic Filariasis. Hooper et al, Annals of Tropical Medicine & Parasitology, Volume 103, 2009 –

July 20, 2009

The development of albendazole for lymphatic filariasis

Scientific Publication

This review examines the thinking and the processes behind the development of albendazole, from the first ideas in the mid 1980s to the establishment

July 20, 2009

Ten years of managing the clinical manifestations and disabilities of lymphatic filariasis

Scientific Publication

Abstract on progress made in preventing the disability of lymphatic filariasis, the monitoring and evaluation of such disability and its control, and the integration

July 20, 2009

Lymphatic filariasis: patients and the global elimination programme

Scientific Publication

Abstract addressing the central role that filariasis patients have played in the Tanzania Lymphatic Filariasis Elimination Programme to date, and covering some of the clinical

July 20, 2009

GlaxoSmithKline and Merck: private-sector collaboration for the elimination of lymphatic filariasis

Scientific Publication

Abstract on the unique private-sector collaboration of the pharmaceutical companies GlaxoSmithKline (GSK) and Merck & Co., Inc., Kenilworth, N.J., U.S.A.,* to support the global efforts to

July 20, 2009

Challenges for the integration of mass drug administrations against multiple ‘neglected tropical diseases’

Scientific Publication

Abstract on the integration of mass drug administrations against multiple NTDs. Hopkins, Annals of Tropical Medicine & Parasitology, Volume 103, 2009 – Issue sup1.

July 20, 2009

A decade of ivermectin–albendazole donation for lymphatic filariasis

Scientific Publication

Article on a symposium held to commemorate the 10th anniversary of the donation of Mectizan® and albendazole for the elimination of lymphatic filariasis. Hopkins

July 20, 2009

The Mectizan Donation Program (MDP)

Scientific Publication

Abstract on the Mectizan® Donation Program (MDP), which was launched in 1987 by Merck & Co., Inc., Kenilworth, N.J., U.S.A.* Thylefors, Annals of Tropical Medicine and

September 20, 2008

Prévention communautaire à domicile des incapacités dues à la filariose lymphatique

Français, WHO Guide

Illustrated instructional guide on caring for symptoms of lymphatic filariasis, French. WHO, 2003.

July 13, 2003

World Health Assembly Resolution: Elimination of lymphatic Filariasis as a Public Health Problem, 1997

WHA Resolution

WHO World Health Assembly Resolution on Lymphatic Filariasis. WHA 50.29, 1997 RESOLUTIONS AND DECISIONS1 WHA50.29 Elimination of lymphatic filariasis as a public health

May 13, 1997

Hub Topic: Lymphatic Filariasis